Kinarus receives 7 Million CHF Grant from the Swiss Federal Funding Programme for COVID-19 Medicines
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Alle Kategorien
Glarner Kantonalbank lanciert Wärmehypothek zum Null-Tarif
» Report
Roche Group: Genentech Press Release - December 12, 2021
» Report
Idorsia to further characterize lucerastat for the treatment of Fabry disease by continuing the open-label extension of the Phase 3 MODIFY study
» Report
Remarquable résultat d'Helvetia (CH) Swiss Property Fund pour l'exercice 2021
» Report
Helvetia (CH) Swiss Property Fund posts strong result for the 2021 financial year
» Report
Helvetia (CH) Swiss Property Fund mit starkem Ergebnis im Geschäftsjahr 2021
» Report
Forbo Holding: Rückkaufangebot zum Festpreis beendet
» Report
Forbo Holding: Fixed-price buyback offer completed
» Report
Roche: Interim data from phase III HAVEN 6 study demonstrate favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A
» Report
Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine
» Report
Credit Suisse Group announces appointments to the Executive Board in line with its new strategy; new Board of Directors leadership appointments to enhance governance of subsidiary Boards
» Report
Bossard Gruppe: Veränderung in der Konzernleitung
» Report
Bossard Group: Change in the Group Executive Committee
» Report
SGS: Brazil Revises Compliance Date for Pacifier Conformity Identification Seals
» Report
Molecular Partners Confirms Ensovibep Retains Neutralization of Omicron Variant of SARS-CoV-2 in Preclinical Studies
» Report
European Centre for Disease Prevention and Control: Epidemiological update: Omicron variant of concern (VOC) – data as of 11 December 2021 (12:00)
» Report
Novartis Scemblix® demonstrates sustained response rate in 48-week follow-up in patients with chronic myeloid leukemia
» Report
Novartis Kymriah® demonstrates strong responses in high-risk patients with relapsed or refractory follicular lymphoma in extended study follow-up
» Report
Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab
» Report
